KVH Industries, Inc.
$74.90M- Market cap
- $130.80M
- Debt
- +$14.01M
- Cash
- −$69.91M
Capital structure 90% equity / 10% debt · EV / Revenue 0.67x · EV / EBITDA 23.54x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: KVHI stock price at discount vs VNDA $7.21 current versus $9.30 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at VNDA's multiple
Implied fair value · at KVHI's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: KVHI FY 2025 (ended Dec 31, 2025) · VNDA FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 90% equity / 10% debt · EV / Revenue 0.67x · EV / EBITDA 23.54x
Capital structure 81% equity / 19% debt · EV / Revenue 1.49x
VNDA carries the larger enterprise value at $321.69M against $74.90M; KVHI trades on the lower EV / Revenue multiple (0.67x vs 1.49x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
KVH Industries, Inc. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
VANDA PHARMACEUTICALS INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.11x
0.24x
Net debt / EBITDA
Leverage against operating earnings
-17.57x
0.05x
Cash and equivalents
Liquid reserves on the balance sheet
$69.91M
$84.85M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
L3HARRIS TECHNOLOGIES, INC. /DE/
KVHI vs LHX
VIASAT INC
KVHI vs VSAT
Iridium Communications Inc.
KVHI vs IRDM
SUPERNUS PHARMACEUTICALS, INC.
KVHI vs SUPN
CATALYST PHARMACEUTICALS, INC.
KVHI vs CPRX
Harmony Biosciences Holdings, Inc.
KVHI vs HRMY
ELI LILLY & Co
KVHI vs LLY
INCYTE CORP
KVHI vs INCY
Sarepta Therapeutics, Inc.
KVHI vs SRPT
$14.01M
$78.23M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.